8-Carboxamidocyclazocine

From WikiMD's WELLNESSPEDIA

Chemical Compound
Identifiers
CAS Number
PubChem CID
ChemSpider ID
UNII
ChEBI
ChEMBL
Properties
Chemical Formula
Molar Mass
Appearance
Density
Melting Point
Boiling Point
Hazards
GHS Pictograms [[File:|50px]]
GHS Signal Word
GHS Hazard Statements
NFPA 704 [[File:|50px]]
References

8-Carboxamidocyclazocine is a chemical compound that belongs to the class of benzomorphan opioids. It is structurally related to cyclazocine, a well-known opioid receptor agonist and antagonist.

Chemical structure and properties[edit]

8-Carboxamidocyclazocine is a derivative of cyclazocine, characterized by the presence of a carboxamide group at the 8-position of the benzomorphan skeleton. This modification alters its binding affinity and activity at various opioid receptors.

Pharmacology[edit]

8-Carboxamidocyclazocine acts as a kappa-opioid receptor agonist and a mu-opioid receptor partial agonist. The kappa-opioid receptor activity is associated with its potential analgesic effects, as well as its ability to produce dysphoria and hallucinations in some cases. The mu-opioid receptor activity contributes to its analgesic properties but also limits its use due to potential for abuse and dependence.

Potential therapeutic uses[edit]

Research into 8-Carboxamidocyclazocine has focused on its potential as an analgesic with reduced abuse potential compared to traditional mu-opioid receptor agonists. Its kappa-opioid receptor activity may also make it useful in treating conditions such as depression and anxiety, although these applications are still under investigation.

Side effects and safety[edit]

As with other kappa-opioid receptor agonists, 8-Carboxamidocyclazocine may cause side effects such as dysphoria, hallucinations, and sedation. Its safety profile is not fully established, and further research is needed to determine its long-term effects and potential for abuse.

Related pages[edit]